Skip to content

Repetitive Transcranial Magnetic Stimulation in Post-Traumatic Stress Disorder

Comparison of Treatment with Repetitive Transcranial Magnetic Stimulation Combined with Drug Therapy with Drug Therapy Alone in Post-Traumatic Stress Disorder

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171205037768N2
Enrollment
30
Registered
2021-01-16
Start date
2018-04-09
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-trumatic stress disorder. Post-traumatic stress disorder (PTSD)

Interventions

Intervention 1: Intervention group or A: Group of patients with post-traumatic stress disorder Simultaneously with taking the drug were treated with r-TMS at a frequency of 1 Hz for 20 minutes with a

Sponsors

Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age 18 to 60 years old History of PTSD According to Beck Depression Inventory did not get a score above 17. At least four weeks (the minimum duration of drug effect) have elapsed since the start of drug treatment

Exclusion criteria

Exclusion criteria: Accompanied by other mental illnesses including depression History of epilepsy or seizures History of Drug Abuse History of severe head trauma or other severe neurosurgery complications Having any type of metal implant Using Pace Receive any type of electroconvulsive therapy for the past 6 months Current pregnancy Receive CBT (cognitive-behavioral therapy) at the same time with the study

Design outcomes

Primary

MeasureTime frame
Post-traumatic stress disorder score based on CAPS questionnaire. Timepoint: Weeks 0, 2, 4 and 8. Method of measurement: CAPS questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarjan Mahmudian

Qazvin University of Medical Sciences

Marjanmahmudian@gmail.com+98 28 3355 5054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026